To include your compound in the COVID-19 Resource Center, submit it here.

Lilly meets 3Q Street estimate; warns for '02

LLY reported third quarter EPS of $0.68, which met the consensus estimate, but

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE